OSE Immunotherapeutics and ARCAGY – GINECO Announce Initiation of a Randomized Phase 2 Clinical Trial Evaluating Tedopi® in Combination with Pembrolizumab in Ovarian Cancer
This clinical trial will be sponsored and conducted by the French oncology cooperative group ARCAGY-GINECO…